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Abstract
Background: Hypertensive disorders complicating pregnancy (HDCP) continues to be a leading cause of maternal
and neonatal mortality and morbidity. The clinical value of placental three-dimensional power Doppler (3DPD) in
assessing HDCP requires further confirmation. The research was developed to assess changes of placental vascularity in
HDCP using 3DPD and to investigate the placental vascularity in small for gestational age (SGA) compared with not-SGA
in patients with HDCP.
Methods: There were 126 normotensive and 128 hypertensive pregnant women included in this prospective
case–control study from March 2011 to March 2013. Pregnant women underwent 3DPD. Vascularization index
(VI), flow index (FI) and vascularization flow index (VFI) were obtained. The placental 3DPD indices, umbilical
artery systolic and diastolic ratio (S/D) and pregnancy outcomes were compared between the groups.
Results: The placental VI and VFI were significantly lower in hypertensive women compared with normotensive women
(P < 0.001 and P = 0.014, respectively), and these parameters were significantly reduced in severe preeclampsia (P < 0.001
and P = 0.003, respectively). A weak correlation was found between VI and umbilical artery S/D in HDCP group (r = -0.277,
P = 0.001). In HDCP population, neonates who were postnatally diagnosed with SGA had lower VI (P = 0.041) and higher
S/D (P < 0.001).
Discussion: The placental vascularity indices decreased in hypertensive women and the reduction inplacental perfusion
was consistent with the severity of the hypertensive disorder. The associations betweenplacental vascularization and
umbilical artery impedance may be valuable for further researches and arerequired confirmation. The significant
differences in the 3DPD placental vascularization between SGA andnot-SGA in hypertensive pregnancy population may
show some clinical importance that we could use tobetter assess or predict the progression and adverse outcomes in the
future. Although 3DPD quantificationhas been widely used in multiple publications, we have to acknowledge its
limitations.
Conclusions: The intraplacental vascularization was poor in HDCP, and especially in severe preeclampsia. Neonates with
SGA had poor placental vascularization and higher umbilical artery S/D. Further studies should focus on the clinical
assessment of placental 3DPD as well as a combination of placental 3DPD and other fetal Doppler indices to better
predict the development and outcomes of preeclampsia.
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Background
Hypertensive disorders complicating pregnancy (HDCP)
continues to be a leading cause of maternal and neonatal
mortality and morbidity [1]. The prevalence of HDCP is
approximately 5.22 % of all pregnancies in China and
8–10 % worldwide [2, 3]. In recent years, important
advances have been made in our understanding of the
pathogenesis and pathophysiology of preeclampsia, but
most of the factors that contribute to the disease remain
unclear. Multiple tests and combination tests have been
developed as screening methods for preeclampsia,
including maternal serum biomarkers and Doppler
parameters. To date, there is no effective screening test
for HDCP [4–6].
HDCP is currently considered as a chronic placental
disease. Placental dysfunction and hypo-perfusion play
an important role in HDCP pathophysiology and are
considered to be responsible for pathologic pregnancy
outcomes, such as fetal growth restriction and perinatal
loss [7–9]. Three-dimensional power Doppler (3DPD)
has been a focal point of recent placental research; it is
superior to 2D Doppler in several ways, including its
ability to detect the secondary and tertiary stem vessels
in the placenta and intraplacental vessel characteristics,
such as the vessel density, branching, caliber changes
and tortuosity, which can be shown using 3DPD [8, 10, 11].
Quantitative 3DPD analysis has been used to assess placen-
tal perfusion and vascularization indices, which potentially
reflect both utero-placental and feto-placental blood
perfusion [10].
Assessment of placental perfusion using 3DPD seems
to be more helpful in understanding HDCP pathophysi-
ology. However, the clinical value of placental 3DPD in
assessing HDCP requires confirmation. The aim of our
study was to compare changes in placental vascularity
between HDCP and normotensive subjects using 3DPD,
and to assess whether placental vascularity changes pre-
senting in small for gestational age (SGA) compared
with not-SGA in HDCP.
Patients and methods
Enrolment
This was a prospective case–control study that was con-
ducted at the First Affiliated Hospital of Xi’an Jiaotong
University, ShaanXi, China, from March 2011 to March
2013. Women with HDCP were enrolled, and normoten-
sive pregnant women were used as controls. HDCP and
normotensive pregnant subjects were individually matched
by maternal age ± 2 years and gestational week at
examination ±2 weeks.
The hypertensive group was further stratified into
the following subgroups: (1) gestational hypertension
(hypertension for the first time during pregnancy
without proteinuria); (2) severe preeclampsia (diastolic
BP ≥110 mmHg, systolic BP ≥160 mmHg; proteinuria
from none to positive; elevated serum creatinine and
transaminase levels; obvious fetal growth restriction
(FGR); multi-organ disturbances, such as headache,
visual disturbance, upper abdominal pain, oliguria,
convulsion, thrombocytopenia and pulmonary edema);
(3) nonsevere preeclampsia (diastolic BP <110 mmHg,
systolic BP <160 mmHg; proteinuria from none to
positive; no multi-organ disturbances or only minimal
serum transaminase elevation). Nonsevere preeclampsia
includes “mild” and “moderate” hypertension, which is not
specifically defined. Overt proteinuria may not be a neces-
sary element to characterize preeclampsia syndrome [12].
Hypertension was defined as systolic blood pressure
(SBP) ≥140 mmHg and/or diastolic blood pressure
(DBP) ≥90 mmHg on at least two occasions at a 6-hour
interval.
All women with fetal chromosomal abnormalities, fetal
malformations, placental anomalies (bipartite placenta
or velamentous insertions), umbilical anomalies, compli-
cations associated with pregnancy (including diabetes
mellitus, intrahepatic cholestasis, thrombophilia and
thrombocytopenia), systemic vascular or autoimmune
disorders, multiple pregnancies, or rupture of amniotic
membrane as well as women receiving vasoactive drugs
or those in active labor were excluded from the study.
Control participants were healthy and normotensive
pregnant women.
The study was approved by the ethics and research
committee of the First Affiliated Hospital of Xi’an Jiaotong
University. The purpose and procedures of the study were
explained to all enrolled participants and written informed
consent was obtained from each participant.
3DPD assessment
A single operator (Ting Yuan) performed all ultrasound
scans using aVoluson E8 (GE Medical Systems, Milwaukee,
WI, USA) ultrasound system. In addition to routine ultra-
sound, the placental 3DPD was performed in all women.
Placental vascularization was assessed using 3DPD.
Because placental blood perfusion varied from region to
region, we standardized the process by choosing five dif-
ferent sampling sites, according to Guiot [13]. The five
spherical sampling sites in each placenta were as follows:
one central, two peripheral at opposite sides and one
between the central site and each peripheral site.
The peripheral sampling spheres were always positioned
to maintain a minimum distance of approximately 4 mm
between the insonated region and both the chorionic and
basal plates. Maximal sensitivity was ensured using the
following settings: pulse repetition frequency (PRF),
0.6 kHz; wall motion filter (WMF), low 1; frequency, mid;
dynamic, 3; balance, 4150; smooth, 4/5; ensemble, 11; line
density, 8; power Doppler map, 4; artefact suppression,
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off; power Doppler line filter, off; and quality, high. The
placenta was investigated using a constant volume and the
same 25-degree sector angle throughout. The spheres
were kept away from the spiral arteries and they were
placed near the basal and/or chorionic plate (Fig. 1). The
3D Glass Body render mode was used, in which the colour
and the grey value information are processed and com-
bined to give a 3D image. The vascularization indices were
obtained using the Virtual Organ Computer-aided
Analysis (VOCAL) program. The manual mode was set,
and the five spherical regions of interest in each placenta
were manually encircled by rotating 30 degrees six times,
respectively. The sphere volume did not include vessels
from the basal and chorionic plates, and it was kept
constant. A histogram automatically showed the
vascularization indices. The three-dimensional volume
was formed using basic units called voxels. The voxel
contains all information about the grey scale and
colour, according to an intensity scale that ranges
from 0 to 100. The vascularization indices are as follows:
vascularization index (VI) refers to the colour voxel-to-
total voxel ratio, indicating the number of vessels that
could be detected within the placental volume; flow index
(FI) refers to the weighted colour voxel divided by the
total colour voxel ratio and provides an amplitude value
for the colour signal, which indirectly estimates the pla-
cental blood flow during a 3D sweep; vascularization flow
index (VFI) refers to the weighted colour voxel-to-total
voxel ratio, which indicates a combination of vascularity
and blood flow. The three index values were obtained
from each sampling measurement, and the average value
of the three indices from five measurements was provided
for the final statistical analysis.
The systolic and diastolic ratio (S/D) of the umbilical
artery Doppler measurement was used for the final ana-
lysis. Other records were reviewed to evaluate the preg-
nancy outcomes, including the delivery mode, delivery
week, neonatal birth weight, Apgar scores and the diagno-
sis of small for gestational age (SGA). SGA was confirmed
at birth by a newborn weight <2 standard deviations (SDs)
below the mean for gestational age [14]. The gestational
age was calculated using the last menstruation period
(LMP) or confirmed based on the results of the first tri-
mester ultrasound.
Statistical analysis
Data gathered from the study subjects were verified and
double-entered into a data management system. Variables
are presented as the mean ± SD or median (range) and
percentages, as appropriate. Statistical analysis was per-
formed using the Pearson, χ2, Fisher exact, Student’s t,
Mann–Whitney U, analysis of variance, Kruskall-Wallis
and Steel Dwass tests, as appropriate. The following
variables were compared between the groups: mater-
nal age, gestational week at examination, parity, SBP,
DBP, placental vascularity (VI, FI and VFI), umbilical
artery S/D, delivery mode, delivery week, Apgar
scores and SGA diagnosis. Correlation analysis was
performed using Spearman rank analysis between placen-
tal vascularity and umbilical artery S/D. All reported P
values were 2-tailed, and values <0.05 were considered sta-
tistically significant. Statistical analysis was performed
using SPSS version 16.0 (IBM, Armonk, NY, USA) and
GraphPad Prism version 5.0 (GraphPad, La Jolla, CA).
Results
A total of 264 pregnant women were initially enrolled, but
2 were diagnosed with intrahepatic cholestasis, 2 were
diagnosed with gestational diabetes and 6 were lost to
follow-up. As a result, 126 normotensive women and 128
hypertensive pregnant women were included in the final
analysis. In the hypertensive group, there were 38 patients
with gestational hypertension, 40 patients with mild
preeclampsia and 50 patients with severe preeclampsia.
Table 1 shows the characteristics of the normotensive
and hypertensive pregnant women. There were similar
maternal ages, gestational weeks at examination and parity
in both groups. The SBP and DBP were significantly
higher in the hypertensive group than in normotensive
group. The placental VI and VFI were significantly lower
in the hypertensive group than in the normotensive
women (P < 0.001 and P = 0.014, respectively). The umbil-
ical artery S/D increased significantly in the hypertensive
group compared with the normotensive group (P = 0.001).
Overall, hypertensive pregnant women (median delivery
gestational age, 36.43 weeks) delivered earlier than
pregnant women in the control group (median delivery
gestational age, 39.57 weeks; P < 0.001). Additionally, the
delivery mode was significantly different, with a higher
frequency of caesarean section and induced labor with
amniotic cavity injection in the hypertensive group
Fig. 1 Assessment of the placental 3DPD at 25 weeks gestation in
normal pregnancy
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compared with the normotensive group (P < 0.001).
There were more neonates with 1-minute Apgar
scores <7 and more neonates diagnosed with SGA in
the hypertensive group compared with the controls
(P < 0.001 and P = 0.004, respectively).
Table 2 shows the characteristics and results among
normotensive patients and those with different types of
hypertension. The demographic information was similar
between the groups. Compared with normotensive
subjects, patients with severe preeclampsia had a
significant reduction in the placental VI (P < 0.001) and
VFI (P = 0.001), as well as a significant increase in umbil-
ical artery S/D (P < 0.001), but there was no difference
with the other types of hypertension (Figs. 2, 3, 4 and 5).
The delivery week, SGA diagnosis and 1-minute Apgar
scores <7 were compared between groups, and patients
with severe preeclampsia delivered the earliest and had
the highest frequency of neonates with SGA as well as a
1-minute Apgar score <7.
Table 3 shows the correlation between placental vascu-
larity and umbilical artery S/D. There were no correla-
tions in the normotensive population. However, the
correlation between VI and S/D was significant (P = 0.001)
in the hypertensive population, but the correlation was
relatively weak (r = –0.277).
Table 4 shows the comparison of patient characteris-
tics and placental vascularity based on a postnatal SGA
diagnosis only in the hypertensive population (for 128
hypertensive pregnant women, 117 neonates were alive).
Neonates that were diagnosed with SGA were born sig-
nificantly earlier than those with normal birth weights.
The placental VI and umbilical artery S/D were signifi-
cantly different in hypertensive pregnancies, resulting in
SGA neonates (P = 0.041 and P < 0.001, respectively).
Discussion
Quantitative 3DPD histogram assessments of placental
vascularization and blood flow have become feasible
because of recent advances [10, 15]. Merce LT et al. [15]
and some other authors reported that there were
positive correlations between gestational age and the
placental vascularization indices, and more placental
trees and placental blood perfusion are available as
gestation progresses in normal pregnancies [16, 17].
However, de Paula CF et al. [18] demonstrated that all
placental vascular indices estimated by 3DPD presented a
Table 1 Characteristics, placental vascularity and neonatal outcomes in the normotensive and hypertensive groups
Parametera Normotensive(n = 126) Hypertensive(n = 128) P
Age, yrs 29.14 ± 4.22 29.76 ± 4.82 0.341




SBP, mmHg 110(85–125) 150(130–230) <0.001
DBP, mmHg 70(56–87) 100(90–158) <0.001
VI 24.47(10.56–48.22) 18.49(10.49–49.55) <0.001
FI 43.89(7.26–92.80) 41.50(1.02–97.70) 0.620
VFI 10.47(0.91–31.54) 7.55(0.11–44.20) 0.014
Um-S/D 2.23(1.44–3.55) 2.48(1.54–5.92) 0.001
Delivery mode, n <0.001
vaginal 59 12
cesarean 67 105
Induced labor 0 11
Gestational age at delivery,wks 39.57(34.14–42.00) 36.43(22.29–41.71) <0.001
Postnatal SGA, n <0.001
Yes 3 26
No 123 91
1-m-Apgar score, n 0.004
< 7 3 12
≥ 7 123 105
aSBP systolic blood pressure, DBP diastolic blood pressure, VI vascularization index, FI flow index, VFI vascularization flow index, Um-S/D umbilical artery systolic
and diastolic ratio, SGA small for gestational age
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Table 2 Characteristics, placental vascularity and neonatal outcomes in different subgroups
Parametera Normotensive (n = 126) Gestational hypertension (n = 38) Nonsevere PEb (n = 40) Severe PEb (n = 50) P
Age, yrs 29.14 ± 4.22 29.56 ± 5.21 28.96 ± 6.23 30.81 ± 5.56 0.371
Gestational age at examination, wks 35.00(22.57–42.00) 37.23(34.57–41.57) 36.50(34.00–39.25) 35.53(21.14–38.56) 0.070
Parity, n 0.131
Nulliparous 100 33 27 35
Mutiparous 26 5 13 15
SBP, mmHg 110(85–125) 133(130–145) 148(140–155) 180(160–230) <0.001
DBP, mmHg 70(56–87) 95(90–98) 95(90–105) 130(115–158) <0.001
VI 24.47(10.56–48.22) 23.38(12.17–40.94) 23.13(12.88–49.55) 16.22(10.49–43.06) <0.001
FI 43.89(7.26–92.80) 55.21(2.06–97.70) 32.70(2.30–95.96) 38.16(1.02–89.54) 0.282
VFI 10.47(0.91–31.54) 10.56(0.28–32.48) 11.81(0.30–44.20) 7.09(0.11–36.62) 0.003
Um-S/D 2.23(1.44–3.55) 2.25(1.63–3.51) 2.42(1.60–3.27) 2.74(1.54–5.92) <0.001
Delivery mode, n <0.001
vaginal 59 9 3 0
cesarean 67 29 37 39
Induced labor 0 0 0 11
Gestational age at delivery, wks 39.57(34.14–42.00) 38.86(33.86–41.71) 37.71(30.14–40.28) 34.79(22.29–41.00) <0.001
Postnatal SGA, n <0.001
Yes 3 6 7 13
No 123 32 33 26
1-m-Apgar score, n <0.001
< 7 3 0 2 10
≥ 7 123 38 38 29
aSBP systolic blood pressure, DBP diastolic blood pressure, VI vascularization index, FI flow index, VFI vascularization flow index, Um-S/D umbilical artery systolic
and diastolic ratio, SGA small for gestational age
bPE preeclampsia
Fig. 2 The placental VI in different population subgroups. The horizontal bar within each box corresponds to the median. The upper and lower bars of
each box correspond to the first and third quartiles, respectively. The vertical whiskers outside each box extend to the smallest and largest observations
within a 1.5 interquartile range (third-first quartiles). The symbols of▲, ● and ■ represented the comparisons of parameters between normal group and
gestational hypertension, normal group and nonsevere PE, normal group and severe PE. * represented a significant difference. PE = preeclampsia. For
placental VI, P values of▲, ● and ■ were 0.32, 0.61 and <0.001, respectively
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constant distribution throughout gestation in spite of the
increase in placental volume according to gestational age.
According to previous studies, the placental vascularity
indices decreased in hypertensive women compared with
normal pregnancies, which has been demonstrated by
many authors [19–22]. In the current study, we also
found that, compared with normotensive pregnancies,
there was less intraplacental vascularization in hyperten-
sive pregnant women, and intraplacental vascularization
was the worst in women with severe preeclampsia. Intra-
placental vascularization in gestational hypertension and
nonsevere preeclampsia did not differ from that in the
normotensive group. However, superimposed preeclampsia
was also found to have the most significant reduction in
placental perfusion when compared amongst hypertensive
disorder subgroups [19]. These results reflected the reduc-
tion in placental perfusion, which was consistent with the
severity of the hypertensive disorder. In preeclampsia, a
disease that reduces the number of vessels in the placental
territory, a lower VI value could be interpreted in the con-
text of deficient trophoblast invasion of spiral arteries [20].
The reduction in VFI indicates that the number of
Fig. 3 The placental FI in different population subgroups. The horizontal bar within each box corresponds to the median. The upper and lower bars of
each box correspond to the first and third quartiles, respectively. The vertical whiskers outside each box extend to the smallest and largest observations
within a 1.5 interquartile range (third-first quartiles). The symbols of▲, ● and ■ represented the comparisons of parameters between normal group and
gestational hypertension, normal group and nonsevere PE, normal group and severe PE. * represented a significant difference. PE = preeclampsia. For
placental FI, P values of▲, ● and ■ were 0.24, 0.81 and 0.24, respectively
Fig. 4 The placental VFI in different population subgroups. The horizontal bar within each box corresponds to the median. The upper and lower bars of
each box correspond to the first and third quartiles, respectively. The vertical whiskers outside each box extend to the smallest and largest observations
within a 1.5 interquartile range (third-first quartiles). The symbols of▲, ● and ■ represented the comparisons of parameters between normal group and
gestational hypertension, normal group and nonsevere PE, normal group and severe PE. * represented a significant difference. PE = preeclampsia. For
placental VFI, P values of▲, ● and ■ were 0.97, 0.70 and 0.001, respectively
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placental trees and blood flow perfusion are decreased.
The FI value could be lower, reflecting placental blood in-
sufficiency, although this was not confirmed in the study.
Damages to placental vessels may be relatively mild in
gestational hypertension and nonsevere preeclampsia, or
in compensatory stage, which presented with no signifi-
cant alterations in the placental vascularity indices.
Both low impedance of placental blood flow and
intraplacental hyperperfusion, which conveys oxygen
and nutrients, are necessary for normal fetal development
and survival during pregnancy. Placental dysfunction and
hypoperfusion are part of the preeclampsia pathophysi-
ology and they correlate with adverse fetal outcomes.
Doppler measurement of the umbilical artery has been
used for decades to assess the fetal condition. Elevated im-
pedance of the umbilical artery and absent end diastolic
velocity (AEDV) or reverse end diastolic velocity (REDV)
denotes a higher risk of survival and adverse outcomes for
the fetus [23, 24]. Therefore, we assessed the correlation
between the placental vascularity and umbilical artery im-
pedance. There was no correlation in normal pregnancies,
but a correlation was present in the hypertensive popula-
tion. A lower placental vascularization was associated with
a higher umbilical artery impedance. Therefore, some fetal
outcomes may be an indirect result of reduced placental
blood flow. Nevertheless, this relatively weak correlation
(r = −0.277) should be taken into account. Doppler meas-
urement of the umbilical artery is usually influenced by
various factors, such as fetal movement and the patient’s
position; thus, further research is required to confirm the
actual correlation.
Pomorski M et al. [25] evaluated the placental vascu-
larity indices between normal pregnancies and FGR
pregnancies, and the indices were all lower in FGR preg-
nancies. They further suggested that VI and VFI were
the best parameters with the most favorable potential to
identify FGR pregnancies. de Almeida PE et al. [19]
studied 62 normotensive and 66 hypertensive pregnant
women, and no placental vascularity differences were
found in neonates who were SGA compared to normal-
sized neonates in the entire population. We compared
the placental vascularity and umbilical artery S/D based
on the postnatal SGA diagnosis in only the hypertensive
population. The neonates who were diagnosed with SGA
had a significantly lower prenatal VI and a higher umbil-
ical artery S/D. Other studies have shown that FGR and
low birth weight were associated with higher umbilical
artery resistance, low placental weight and placental
hypermaturiy, higher frequency of placentas in the III-
level and infarction in the group with a higher umbilical
artery [26, 27]. These results were in accordance with
our findings. There are dysplastic placental villi and
fibrous sediments in the villi, increased areas of athero-
sclerosis, ischemia and infarctions, resulting in a decreased
total cross sectional area of the placental vessels, placental
hypo-infusion and hypoxia, increased resistance of fetal
circulation, elevated umbilical artery S/D, FGR and low
birth weight.
Fig. 5 The umbilical artery S/D in different population subgroups. The horizontal bar within each box corresponds to the median. The upper and
lower bars of each box correspond to the first and third quartiles, respectively. The vertical whiskers outside each box extend to the smallest and
largest observations within a 1.5 interquartile range (third-first quartiles). The symbols of ▲, ● and ■ represented the comparisons of parameters
between normal group and gestational hypertension, normal group and nonsevere PE, normal group and severe PE. * represented a significant
difference. PE = preeclampsia. For umbilical S/D ratio, P values of ▲, ● and ■ were 0.69, 0.62 and <0.001, respectively
Table 3 Correlation between placental vascularity and Um-S/D
in normotensive and hypertensive population
Indexa Normotensive Hypertensive
r P r P
VI 0.132 0.248 −0.277 0.001
FI 0.014 0.904 −0.122 0.159
VFI 0.147 0.196 −0.148 0.088
aVI vascularization index, FI flow index, VFI vascularization flow index
Yuan et al. BMC Pregnancy and Childbirth  (2015) 15:240 Page 7 of 11
Hata T et al. [28] assessed placental perfusion at 18–22
weeks of gestation in a low-risk population to predict
adverse obstetrical complications or outcomes, including
FGR and HDCP. It is the first study to assess 3DPD
placental vascularization at approximately 20 weeks of
gestation in a low-risk population to evaluate whether
reduced endovascular trophoblast invasion and uteropla-
cental artery remodeling occur in pregnant women who
develop FGR or HDCP. However, there were no signifi-
cant differences in the VI, FI, or VFI values between FGR
and normal pregnancies or between HDCP and non-
HDCP pregnancies. Possible explanations for this lack of
difference were the low number of women who developed
adverse outcomes and that most HDCP cases were classi-
fied as nonsevere type. In spite of this, some authors have
reported different results [29, 30]. The VI and VFI
between 11–14 weeks of gestation were significantly lower
in the pregnant women who developed PE and VI, which
may have potential usefulness for the detection of HDCP.
Therefore, it remains unclear whether 3DPD can depict
early impaired proliferation, migration, and invasion of
trophoblasts into the maternal decidua and myometrium
[28]. It is necessary to confirm the true predictive value of
3DPD for placental vascularization in a low-risk popula-
tion. By contrast, the study design we performed was
evaluate whether there were significant differences in the
3DPD placental vascularization between SGA and not-
SGA in the hypertensive pregnancy population instead of
the low-risk population. The findings in Tables 3 and 4
showed the clinical importance of variables that could be
used in combination to better assess or predict the progres-
sion of high-risk pregnancies and their adverse outcomes in
the future. As a result, early precautions and effective inter-
ventions could be made to improve the prognosis.
With respect to the reproducibility of 3DPD ultra-
sound placental index measurements, there is significant
variability for placental 3D power Doppler vascular
index values among previous studies [31]. Merce LT et
al. [32] were the first to reveal the validity of 3DPD, con-
firming the favourable reproducibility of 3DPD vascular
indices in normal pregnancies. Similarly, Hata T et al.
[33] and other researchers also provided intra- and
inter-observer reproducibility applying 3DPD parameters
in the placenta [34–37]. However, though multiple pub-
lications and journal submissions have used 3DPD, the
reliability and reproducibility of 3DPD parameters are
still questioned. Lai PK et al. [38] showed a poor repro-
ducibility at even the most fundamental level in normal
pregnancies. Guimarães Filho HA et al. [37] demon-
strated that the FI was the highest reproducibility index
in normal pregnancies between 26 and 35 weeks. Guiot
C et al. [13] investigated normal and FGR pregnancies
between 23-37 weeks and reported that the FI showed
the least variability between the samples and was lower
than controls only in the group with severe impairment
of feto-placental blood perfusion. The results by Costa J
et al. [22] were consistent with this. However, the study
on 11–14 weeks of normal pregnancy by Tuuli MG et
al. [39] revealed that VI and VFI were the most reliable
indices, while FI showed significant bias towards under-
estimation in placental sonobiopsy research. It is con-
cluded that further investigations on the reproducibility
of placental perfusion and quantification using VOCAL
are still required before 3DPD is applied as a clinical tool
to quantify placental blood perfusion in normal and
complicated pregnancies.
This study had some limitations. While the method of
estimating placental vascularization was standardized and
Table 4 Characteristics and placental vascularity according to postnatal diagnosis of SGA in the hypertensive population
Parametera SGAb P
No(n = 91) Yes(n = 26)
Diagnosis, n 0.122
Gestational H 32 6
Mild PE 33 7
Severe PE 26 13
Age, yrs 29.90 ± 4.88 30.20 ± 4.94 0.800
Gestational age at delivery, wks 37.57(31.71–41.71) 33.85(31.14–38.57) <0.001
VI 19.15(10.49–47.47) 15.49(10.62–49.55) 0.041
FI 45.06(1.02–96.52) 38.97(3.94–97.70) 0.621
VFI 8.00(0.11–44.20) 8.93(0.48–32.39) 0.917
Um-S/D 2.36(1.54–5.92) 3.41(1.94–5.77) <0.001
agestational h = gestational hypertension, PE preeclampsia, VI vascularization index, FI flow index, VFI vascularization flow index, Um-S/D umbilical artery systolic
and diastolic ratio
bSGA small for gestational age
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we considered the vascularization variability throughout
the placenta, the long duration required for the measure-
ment seemed to be a disadvantage.
Although 3DPD quantification has been widely used in
recent studies and publications in the field of obstetrics
and gynecology, we acknowledge that PD quantification
also has several methodological limitations for assessing
vascularization [40, 41]. These limitations include the high
dependence on gain settings, lack of standardized machine
settings [42–45], differences in attenuation [46], and issues
with reproducibility [47–49], which are capable of altering
the VI, FI and VFI quantification. A meaningful interpati-
ent comparison of vascularity cannot be made without
standardization. These issues limit the clinical applicability
of 3DPD imaging. One alternative that could compensate
for the effects of machine settings, attenuation, organ pos-
ition and other confounding factors is fractional moving
blood volume (FMBV), which can provide a more robust
estimation of vascularity [50–54]. However, this method
was not performed in the current study, and more obstet-
rics investigations that use FMBV should be performed in
the future. Additionally, the volumetric pulsatility index
(vPI) assessing the volumetric vascular impedance with
spatiotemporal image correlation (STIC) and VOCAL
could overcome these deficiencies, representing an im-
portant step in the process of standardization [43]. These
alternative methods will be performed in the future.
Additionally, Zalud I et al. [55] demonstrated that there
was a significant difference in the uterine spiral vascula-
ture volume between younger and older women and that
obstetrical complications could be partially related to the
decreased uterine spiral vasculature volume; moreover,
parity influenced all placental 3DPD vascularity indices. In
the current study, there were no significant differences in
maternal age and parity between the groups. However, in
studies on hypertensive pregnancies, it seems necessary to
adjust or stratify these influencing factors to gain more
accurate results in the future.
Conclusion
The intraplacental vascularization was poor in HDCP,
especially in patients with severe preeclampsia. Neonates
who were diagnosed with SGA had poor placental
vascularization and higher umbilical artery S/D. Further
studies should focus on the clinical assessment of pla-
cental 3DPD as well as a combination of placental 3DPD
and other Doppler indices that represent the fetus could
better predict the development and outcomes in patients
with preeclampsia.
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